Oruka Therapeutics, Inc.
ORKA
$68.37
$1.442.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 388.83M | 337.04M | 349.16M | 328.41M | 349.09M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.42M | 6.81M | 6.01M | 3.61M | 2.99M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 395.25M | 343.86M | 355.16M | 332.01M | 352.08M |
|
|
|||||
| Total Current Assets | 395.25M | 343.86M | 355.16M | 332.01M | 352.08M |
| Net Property, Plant & Equipment | 2.01M | 2.12M | 2.22M | 2.25M | 973.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 103.00K | 103.00K | 103.00K | 103.00K | 103.00K |
| Total Assets | 504.48M | 488.62M | 509.25M | 357.42M | 377.11M |
|
|
|||||
| Total Accounts Payable | 3.66M | 4.16M | 2.21M | 4.66M | 3.55M |
| Total Accrued Expenses | 12.29M | 10.60M | 8.66M | 3.70M | 6.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 680.00K | 619.00K | 419.00K | 660.00K | 283.00K |
| Total Finance Division Other Current Liabilities | -- | -- | 9.68M | 3.09M | 1.42M |
| Total Other Current Liabilities | -- | -- | 9.68M | 3.09M | 1.42M |
| Total Current Liabilities | 16.63M | 15.37M | 20.97M | 12.11M | 11.72M |
|
|
|||||
| Total Current Liabilities | 16.63M | 15.37M | 20.97M | 12.11M | 11.72M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.13M | 1.31M | 1.49M | 1.67M | 664.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.76M | 16.69M | 22.46M | 13.78M | 12.39M |
|
|
|||||
| Common Stock & APIC | 705.25M | 657.61M | 643.25M | 470.04M | 466.52M |
| Retained Earnings | -220.98M | -189.16M | -159.57M | -129.30M | -104.72M |
| Treasury Stock & Other | -480.00K | 546.00K | 185.00K | -27.00K | -6.00K |
| Total Common Equity | 483.79M | 469.00M | 483.86M | 340.71M | 361.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.93M | 2.93M | 2.93M | 2.93M | 2.93M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.93M | 2.93M | 2.93M | 2.93M | 2.93M |
|
|
|||||
| Total Common Equity | 483.79M | 469.00M | 483.86M | 340.71M | 361.79M |
| Total Preferred Equity | 2.93M | 2.93M | 2.93M | 2.93M | 2.93M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 486.72M | 471.93M | 486.79M | 343.64M | 364.73M |
|
|
|||||